Full Year 2024 Polarean Imaging PLC Earnings Call Transcript

May 8, 2025 / 02:00 PM GMT

Release Date Price: $0.011

Transcript

Key Points

Positve

Polarean Imaging PLC (PLLWF) received FDA approval for the first and only MRI contrast agent, which is being reimbursed in the United States.
The company has successfully expanded its customer base to 22, with 7 clinical systems installed or on order.
Polarean Imaging PLC (PLLWF) has extended its cash runway through Q2 of 2026, providing financial stability.
The company is actively expanding its market by lowering the minimum age for its technology from 12 to 6 years, pending FDA approval.
Polarean Imaging PLC (PLLWF) has announced a new revenue vertical focused on pharma-sponsored trials, enhancing its growth potential.

Negative

Changes in NIH funding and hospital budget constraints have created headwinds, delaying some deals and impacting sales momentum.
The company experienced a cash burn of $6 million in 2024, although this was reduced from the previous year.
Polarean Imaging PLC (PLLWF) will need to raise additional capital before starting the gas exchange clinical trial.
The company faces challenges in penetrating academic medical centers due to tightened budgets and decision-making delays.
Market headwinds, including changes in administration policies, have affected the company's ability to secure deals early in the year.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

POLX.L - Polarean Imaging PLC
Full Year 2024 Polarean Imaging PLC Earnings Call
May 08, 2025 / 02:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon and welcome to the Polarian Imaging PLC for your results briefing. Throughout this recorded presentation, investors will be in listen-only mode. Questions are encouraged and they can be submitted at any time using the Q&A tab situated on the right hand corner of your screen. Simply type in your questions and press send. The company may not be in a position to answer every question it receives during the meeting itself. However, the company can review all questions submitted today and published responses where it is appropriate to do so.

Before we begin, I would like to submit the following poll, and I would now like to hand you over to CEO Christopher Vonnaco. Good afternoon to you.

---------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.